3 weeks ago
21
Sara Appino, The Motley Fool
Sun, August 2, 2026 astatine 1:27 PM CDT 5 min read
Aehr Test Systems (NASDAQ:AEHR) and C3.ai (NYSE:AI) some purpose to capitalize connected the artificial quality boom, but they run connected other ends of the technological spectrum. Which is the amended buy?
Aehr focuses connected the hardware side, providing indispensable investigating instrumentality for chips utilized successful high-growth markets similar electrical vehicles and information centers. C3.ai provides the bundle layer, helping monolithic organizations deploy predictive artificial quality applications. Both companies are navigating a shifting scenery wherever accelerated innovation meets lumpy gross cycles.
The lawsuit for Aehr Test Systems
Aehr Test Systems designs and sells specialized instrumentality utilized to trial chips astatine the wafer level to place defects earlier they scope last assembly. The institution is simply a niche subordinate among semiconductor stocks, providing indispensable investigating instrumentality for silicon carbide chips. Customer attraction similar this adds a furniture of hazard to the business, arsenic its 5 largest customers accounted for astir 70% of nett revenues successful fiscal 2026.
In FY 2026, gross reached adjacent to $50.0 million, representing a diminution of astir 15.2% compared to the erstwhile year. This gross driblet contributed to a nett nonaccomplishment of astir $7.1 cardinal for the period. The nett margin, which shows however overmuch of each dollar earned becomes nett aft each expenses, was astir -14.3%.
As of its May 2026 equilibrium sheet, the institution maintains a existent ratio of astir 10.3x. The existent ratio measures a firm's quality to screen short-term debts with short-term assets, with a higher fig mostly suggesting amended liquidity. The debt-to-equity ratio is astir 0.0x, indicating the institution holds negligible indebtedness comparative to its shareholder equity portion escaped currency travel was astir -$5.4 million.
The lawsuit for C3.ai
C3.ai builds endeavor bundle that allows ample organizations to make and tally artificial quality applications astatine scale. The institution focuses connected industries with analyzable information needs, specified arsenic lipid and gas, defense, and manufacturing, done partnerships with Baker Hughes and Shell. It is presently transitioning toward a consumption-based pricing exemplary to pull much customers and amended semipermanent adoption.
In FY 2026, gross reached astir $250.3 million, which is simply a diminution of astir 35.7% from the anterior year. This little top-line show resulted successful a nett nonaccomplishment of adjacent to $470.4 million. The nett borderline for the fiscal twelvemonth was astir -187.9%, suggesting that expenses importantly outpaced gross during this play of concern transformation.
English (CA) · 
English (US) · 
Spanish (MX) ·